Suppr超能文献

高原探险期间凝血参数的变化。

Changes of coagulation parameters during high altitude expedition.

机构信息

Center of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland.

出版信息

Swiss Med Wkly. 2010 Feb 20;140(7-8):111-7. doi: 10.4414/smw.2010.12910.

Abstract

PRINCIPLES

Data on changes of haemostatic parameters at altitudes above 5000 m are very limited. So far it is unknown, whether altered coagulation could contribute to the development of acute mountain sickness.

METHODS

Thirty four healthy mountaineers were randomised to two acclimatisation protocols and undertook an expedition on Muztagh Ata (7549 m) in China. Tests were performed at five altitudes up to 6865 m. Haemostatic parameters, such as PT, aPTT, D-Dimer, APC-Resistance (APCR), von Willebrand Factor activity (RCo), ADAMTS-13 & C-Natriuretic Peptide (CNP) were assessed together with Lake Louise AMS score.

RESULTS

D-Dimer significantly increased with increasing altitude (median 0.62 to 0.81 mcg/L, p <0.0001). During ascent, PT increased (83% to >100%) and APCR decreased significantly from 0.95 to 0.8 (p <0.01). Furthermore, a significant increase of aPTT (38 to 43 sec) was paralleled by significant changes of RCo (102% to 62%) (both p <0.001). There were no significant changes in ADAMTS-13 and CNP. No significant relationship between investigated parameters and AMS scores could be detected. When comparing the participants of the two acclimatisation protocols, there was an overall higher RCo in patients with a faster ascent protocol (p = 0.04). This was accompanied by lower ADAMTS-13 of the coagulation system in these patients (p = 0.04).

CONCLUSIONS

Coagulation parameters change significantly during hypobaric hypoxia. Whereas we could detect no association between AMS scores and coagulation parameters, our results do show some parameters to be associated with an acclimatisation protocol and a successful ascent to the summit.

摘要

原则

关于海拔 5000 米以上止血参数变化的数据非常有限。到目前为止,还不清楚改变的凝血是否会导致急性高山病的发生。

方法

34 名健康登山者被随机分配到两种适应方案,并在中国的慕士塔格峰(7549 米)进行了探险。在海拔 6865 米以下的五个高度进行了测试。评估了止血参数,如 PT、aPTT、D-二聚体、APC 抵抗(APCR)、血管性血友病因子活性(RCo)、ADAMTS-13 和 C-利钠肽(CNP),并与路易斯湖 AMS 评分一起评估。

结果

随着海拔的升高,D-二聚体显著增加(中位数 0.62 至 0.81 mcg/L,p <0.0001)。在上升过程中,PT 增加(83%至> 100%),APCR 从 0.95 降至 0.8(p <0.01)。此外,aPTT(38 至 43 秒)显著增加,同时 RCo(102%至 62%)显著变化(均 p <0.001)。ADAMTS-13 和 CNP 无明显变化。未发现研究参数与 AMS 评分之间存在显著关系。当比较两种适应方案的参与者时,在上升速度较快的方案中,患者的 RCo 总体较高(p = 0.04)。这伴随着这些患者凝血系统中 ADAMTS-13 的降低(p = 0.04)。

结论

在低压缺氧环境下,凝血参数会发生明显变化。虽然我们没有发现 AMS 评分和凝血参数之间存在关联,但我们的结果确实表明某些参数与适应方案和成功登顶有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验